Experience of a vasopressin receptor antagonist, tolvaptan, under the unique indication in Japanese heart failure patients

Clin Pharmacol Ther. 2013 Oct;94(4):449-51. doi: 10.1038/clpt.2013.147. Epub 2013 Jul 19.

Authors

K Kinugawa¹, T Imamura, I Komuro

Affiliation

¹ Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

PMID: 23872863
DOI: 10.1038/clpt.2013.147

No abstract available

MeSH terms

Antidiuretic Agents / therapeutic use*
Antidiuretic Hormone Receptor Antagonists*
Benzazepines / therapeutic use*
Heart Failure / drug therapy*
Humans
Japan
Osmolar Concentration
Tolvaptan

Substances

Antidiuretic Agents
Antidiuretic Hormone Receptor Antagonists
Benzazepines
Tolvaptan